Letter: Anterior urethropexy offers excellent, low-risk option to mesh

Article

"Practicing medicine is difficult enough these days without doing things to enrich innovation-stifling lawyers," writes Jack Francis, MD.

To the editor: 

As an old retired urologist, I’ve seen and done most of the procedures used for treatment of stress urinary incontinence. With the litigious world of today, I am befuddled why anyone would want to expose themselves to a lawsuit by doing any of the mesh procedures when an excellent, low-risk, highly successful procedure is available.

The anterior urethropexy (Lapides, MMK, Burch) uses absorbable suture (gut) and can be done laparoscopically, robotically, or with a short transverse muscle-splitting incision. Success should be in the 95% range. The procedure can be individualized to suit the skills of the urologist. It basically results in fixing the anterior urethra, bladder neck, and bladder dome anteriorly to the periosteum of pubis and rectus fascia.

Admittedly there are negatives, although not many. Overnight stay may be necessary, and a catheter may need to be left for 1-2 days. But pain is usually mild. Urinary retention is rare, as are long-term complications.

Sometimes modifying older procedures is comparable to devising new ones. Practicing medicine is difficult enough these days without doing things to enrich innovation-stifling lawyers. Watch TV some night and note the ads for nonsensical lawsuits. Best of luck.

Jack Francis, MD / Laytonsville, MD

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.